SOUTH SAN FRANCISCO, Calif. — The startup’s pitch seems compelling, even commonsensical: About 500,000 women in the U.S. need surgery every year for precancerous cervical lesions caused by the human papillomavirus. The surgery can lead to devastating reproductive consequences.

Antiva Biosciences, a 6-year-old drug maker, is working on a first-in-class treatment that, if successful, could make that surgery unnecessary.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • This is great, but, if pharma has figured out how to reduce the viral counts for HIV/AIDS and for Hepatitis C why can’t we do the same for for HPV. Wouldn’t this stop lesions from occurring in the first place?

    • Personally, I wouldn’t take a systemic drug if I didn’t have to, especially for a problem that in the early stages is highly localized. HPV is common. One thing that we should NOT do is treat everyone who might have the virus when they are not experiencing problems. I have a cousin who developed this kind of lesion. The surgery rendered her unable to become pregnant. This might not happen today, but why take the chance, when a simple treatment like this can cure the lesions without surgery? No wonder women physicians get excited about it. As for male physicians who resist, I think they just like the power of cutting.

  • I believe that it’s time that women fight for women.
    I sdmire the effort that is going to make progress in the future.

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy